Document is current
Any future updates will be listed below
-
Authors
Lee, Chan Joo
Lee, Hokyou
Seo, Jiwon
Hwang, Jinseub
Kang, Dayoung
Park, Soo-Hyun
Hwang, Jin-Taek
Park, Jae Ho
Park, Sungha
- License Information
-
More Information
Article History
Received: 19 May 2024
Revised: 16 October 2024
Accepted: 23 October 2024
First Online: 14 November 2024
Compliance with ethical standards
:
: CJL has received honoraria from Novartis, Organon, Viatris, Boryung, Daiichi Sankyo, Chong Kun Dang, Daewoong, and JW Pharmaceutical. CJL has received stock option from Mediwhale. SP received honoraria from Viatris, Organon, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, Chong Kun Dang, and Daewon, and a research grant from Daiichi Sankyo. SP has received consultation fees from Skylab. In addition, SP received stock options from Mediwhale. The other authors have no conflicts of interest to declare.
: This study complied with the Declaration of Helsinki, and its design was approved by Yonsei University Health System’s Institutional Review Board (institutional review board number: 4-2022-0325). The requirement for informed consent was waived because the data were deidentified and anonymized. We followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines for cohort studies.
